Healthcare Insights

Image related to an article about Neurotech International

Neurotech International share price hits a new 52 week high

Healthcare

Shares in Neurotech International (ASX:NTI) are currently trading close to a 52 week high, with the share price up by around 7.14% to A$0.075 over the past week. On a one-month basis, the Neurotech International price has risen by 25.0...

ASX:NTI

Image related to an article about Jinxin Fertility

What brokers are saying about Jinxin Fertility

Healthcare

When it comes to looking for stock market investment ideas, broker recommendations can be a useful place to start. These city experts tend to know the companies they cover inside-out, so their views can be valuable. They're even more v...

HKG:1951

Image related to an article about Indivior

Why Indivior is a market favourite

Healthcare

Some shares have withstood recent economic shockwaves better than others - but is Indivior (LON:INDV) one of them? To understand why different shares respond to chaos in different ways, it pays to look at their strengths. In bull marke...

LON:INDV

Image related to an article about Prophase Labs

Which way is the Prophase Labs share price trending?

Healthcare

Despite economic uncertainty, shares in Prophase Labs (NAQ:PRPH) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue. Finding stocks with the potential to break-out as t...

NAQ:PRPH

Image related to an article about Eli Lilly and Co

Where next for the Eli Lilly and Co share price?

Healthcare

Shares in Eli Lilly and Co (NYQ:LLY) are currently trading at $324.2 but a key question for investors is how economic uncertainty might affect the price in the months to come. The answer comes down to judging whether Eli Lilly and Co i...

NYQ:LLY

Image related to an article about Abcam

Are analysts upbeat on the outlook for Abcam?

Healthcare

While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the country's largest quoted companies, such as Abcam (LON:ABC).  Abcam is an import...

LON:ABC^L22

Image related to an article about Innovent Biologics

Will the Innovent Biologics share price run continue?

Healthcare

In this article we will quickly re-cap the broker forecasts for Innovent Biologics (HKG:1801). The Innovent Biologics share price has risen by 43.3% over the past month and it’s currently trading at HK$34.9. For investors considering w...

HKG:1801

Image related to an article about Amplitude Surgical SA

Which way to trade Amplitude Surgical SA (EPA:AMPLI)?

Healthcare

As any reader of this is probably aware, shares in Amplitude Surgical SA (EPA:AMPLI) are currently trading close to a 52 week high, with the share price up by around 4.83% to €2.82 over the past week. On a one-month basis, the Amplitud...

EPA:AMPLI

Image related to an article about Fonar

Why Fonar could be well placed to recover from volatility

Healthcare

Research shows that quality and value are two powerful drivers of stock market profits. After the economic turmoil we've seen over the past year, it's possible that these two factors could have an influence on the Fonar (NAQ:FONR) shar...

NAQ:FONR

Image related to an article about UG Healthcare

Four clues to the quality of UG Healthcare (SGX:8K7)

Healthcare

Warren Buffett makes it look so easy: find high-quality companies, wait for a fair price to buy, and then hold them... forever. The problem of course is that these stocks are hard to find - but there are signs that UG Healthcare (SGX:8...

SGX:8K7

Image related to an article about OptiNose

After a strong run, what's next for investors in OptiNose?

Healthcare

If you've ever found yourself feeling increasingly drawn to a stock that's constantly rising in price, you are not alone...  Since the dawn of the stock market, speculators have been captured by the tendency of prices to 'trend'.  When...

NSQ:OPTN

  • Quality
    76
  • Value
    83
  • Momentum
    68
  • StockRank™
    93

Unlock comprehensive stock market insights

Quickly sanity-check any investment idea, with a free trial of Stockopedia's award-winning research platform. Join over 15,000 investors who use Stockopedia to:

  • Access institutional-quality insights on thousands of stocks
  • Make more confident, successful investing decisions
  • Learn from the smartest investor community on the web
Get started for free

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"